Skip to main content
. 2007 Oct;3(5):655–664.

Table 2.

Invasive procedures (N = 29) successfully treated with rFVIIa as first-line therapy (3 non-evaluablea episodes and 2 failuresb not included) (data from Poon (2004))

Bolus injections Median (range) Continuous infusion Median (range)
Major surgery: all 3 episodesc Major Surgery: all 3 episodesd
Dosage (μg/kg per injection) 92(80–92) Initial bolus dosage (μg/kg) 49(28–70)
Doses used (N) 14(4–33) CI dosage (μg/kg/h) 5(5–30)
Duration of treatment (h) 47(11–141) Duration of treatment (h) 282(225–336)
Minor surgery: all 20 epidsodese Minor surgery: all 3 episodesf
Dosage (μg/kg per injection) 109(74–150) Initial bolus dosage (μg/kg) 88(72–110)
Doses used (N) 3(1–19) CI dosage (μg/kg/h) 12(9–20)
Duration of treatment (h) 7(0.1–152) Duration of treatment (h) 67(60–267)
Minor surgery: 9 dental extraction
Dosage (μg/kg per injection) 100(78–134)
Doses used (N) 3(1–19)
Duration of treatment (h) 6(0.1–152)
a

Nonevaluables: two major (pyelonephrectomy, skin grafting) and 1 minor (central catheter insertion).

b

Failures: persistent oozing after endoscopic uterine myometomy; recurrent hematuria following ureteric stent removal.

c

Major by bolus injection: laparotomy, laparoscopic bilateral oophorectomy, hysterectomy.

d

Major by CI: colostomy, colostomy revision, intestinal resection.

e

Minor by bolus injection: Nine dental extractions, 4 other dental procedures, 2 colonoscopy/polypectomy, one each of cystoscopy/ureteric stent insertion, hernia repair, tracheostomy, knee injection, otolaryngological cryosurgery.

f

Minor by CI: central cathetre removal, colonoscopy/polypectomy, cystoscopy/ureteric stent insertion.